Both in Pharmaceuticals
Royalty Pharma vs Teva Pharmaceutical Industries Limited
Over the past year RPRX returned +79.0% and TEVA returned +105.5%; their daily moves had a correlation of 0.41.
RPRX +79.0% TEVA +105.5%Growth of $1, one year, split-adjusted
| Metric | RPRX | TEVA |
|---|---|---|
| Price | $67.18 | $42.09 |
| Market cap | $29.91B | $49.09B |
| Today | +1.90% | +1.50% |
| 1 month | +16.6% | +7.1% |
| 6 months | +35.8% | +20.4% |
| Year to date | +73.9% | +34.9% |
| 1 year | +83.2% | +108.1% |
| Revenue growth (YoY) | +16.5% | −0.8% |
| Gross margin | 100.0% | 52.0% |
| Net margin | 2.7% | −13.9% |
| P/E (TTM) | 36.7× | 69.4× |
| Price / sales | 11.8× | 2.8× |
| Net cash | -$8.23B | -$12.94B |
| Dividend yield | 1.40% | — |
| Volatility (60d) | 24.9% | 27.4% |
| Short % of float | 2.9% | 2.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).